#ROG — FinScans

Release 📈 Stocks

KRAS Inhibitor Market Expands as Roche, Lilly, and Merck Advance Pipelines

October 19, 2026 (22 days ago)

The KRAS inhibitor sector gains momentum as Roche, Eli Lilly, and Merck advance specialized oncology therapies, addressing a growing demand for targeted…

ROG LLY MRK

🌍 GLOBAL Read More →

News 📈 Stocks

Vanguard VT vs. iShares IEFA: Comparing Global and International ETF Options

September 20, 2026 (51 days ago)

VT and IEFA offer distinct geographic and sector exposures, with VT tracking a global index and IEFA focusing exclusively on international developed…

VT IEFA NVDA +5

🌍 GLOBAL Read More →

Analyst 📈 Stocks

UBS Sees 25% Upside for AstraZeneca After 15% Share Price Slide

September 18, 2026 (53 days ago)

UBS maintains a buy rating on AstraZeneca, arguing the recent 15% sell-off is overdone and highlighting the company's path to $80 billion…

AZN BMY ROG +1

🌍 EUROPE Read More →